FAQ

Reviparin sodium

Known as: reviparin-sodium 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2011
012319962011

Related topics

Related topics

1 relation

Broader (1)

reviparin

Related mentions per year

Related mentions per year

1993-2017
1990200020102020
Reviparin sodium
reviparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Reviparin sodium clivarine: a review of its therapeutic use.
Reviparin sodium (clivarine) is a second generation LMWH, developed with the aim of maximising the antithrombotic action while… (More)
Is this relevant?
2002
2002
Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
BACKGROUND Oral anticoagulants and low-molecular-weight heparin are both recommended for venous thromboembolism prophylaxis after… (More)
Is this relevant?
Review
2002
Review
2002
Reviparin sodium - a new low molecular weight heparin.
Reviparin sodium (Clivarine), Knoll AG) is a low molecular weight heparin (LMWH) with a mean peak molecular weight of 3900 Da. It… (More)
Is this relevant?
2001
2001
Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial.
PURPOSE Deep venous thrombosis (DVT) is a common, important complication of major orthopaedic surgery, particularly knee… (More)
Is this relevant?
2001
2001
Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route.
Previous studies in rats show that unfractionated heparin and the low molecular weight heparin logiparin have a dose-dependent… (More)
Is this relevant?
Review
2001
Review
2001
Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
UNLABELLED Reviparin (reviparin sodium) is a low molecular weight heparin (LMWH) that catalyses the inactivation of factors Xa… (More)
Is this relevant?
1997
1997
[Prevention of thromboembolism in minimal invasive interventions and brief inpatient treatment. Results of a multicenter, prospective, randomized, controlled study with a low molecular weight heparin…
A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous… (More)
Is this relevant?
1997
1997
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
BACKGROUND Low-molecular-weight heparin is known to be safe and effective for the initial treatment of patients with proximal… (More)
Is this relevant?
1997
1997
Thromboembolieprophylaxe bei minimal-invasiven Eingriffen und kurzstationärer Behandlung Ergebnisse einer multicentrischen, prospektiven, randomisierten, kontrollierten Studie mit einem…
A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous… (More)
Is this relevant?
Review
1996
Review
1996
Cost-effectiveness of the low molecular weight heparin reviparin sodium in thromboprophylaxis.
Use of low molecular weight heparins (LMWHs) is now generally accepted as an ideal method of prophylaxis against postoperative… (More)
Is this relevant?